Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sympathetic overactivity and the kidney].

Antje Habicht1, Bruno Watschinger

  • 1Klinische Abteilung für Nephrologie und Dialyse, Universitätsklinik für Innere Medizin III, Wien, Osterreich.

Wiener Klinische Wochenschrift
|November 8, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Donor bone marrow together with recipient regulatory T cells induces chimerism without irradiation in kidney transplantation.

Science translational medicine·2026
Same author

Prevalence of Strongyloides stercoralis in haemodialysis patients in Vienna.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2025
Same author

The factor XIa antibody osocimab strongly inhibits clotting in extracorporeal circuits with human blood and in baboons.

Research and practice in thrombosis and haemostasis·2025
Same author

Current practices in prevention, screening, and treatment of diabetes in kidney transplant recipients: European survey highlights from the ERA DESCARTES Working Group.

Clinical kidney journal·2025
Same author

Renal sympathetic denervation 2024 in Austria: recommendations from the Austrian Society of Hypertension : Endorsed by the Austrian Society of Nephrology and the Working Group of Interventional Cardiology of the Austrian Society of Cardiology.

Wiener klinische Wochenschrift·2024
Same author

Novel transcriptomic signatures associated with premature kidney allograft failure.

EBioMedicine·2023

Hypertension in chronic kidney disease (CKD) significantly increases cardiovascular risks and accelerates kidney damage. Sympathetic nervous system overactivity is a key factor, suggesting new therapeutic targets for managing hypertension and slowing CKD progression.

Area of Science:

  • Nephrology
  • Cardiology
  • Hypertension Research

Background:

  • Hypertension is prevalent in chronic renal failure (CRF) patients, contributing to high cardiovascular morbidity and mortality.
  • Hypertension exacerbates renal disease progression.
  • Previously, enhanced sodium retention, hypervolemia, and renin-angiotensin-aldosterone system (RAAS) overactivity were primary suspects for hypertension in CRF.

Purpose of the Study:

  • To review the role of sympathetic overactivity in hypertension associated with chronic renal failure.
  • To explore novel therapeutic strategies targeting sympathetic overactivity for managing renal disease progression and cardiovascular risk.

Main Methods:

  • Review of experimental and clinical studies.
  • Analysis of the impact of sympatholytic drugs (RAAS inhibitors, beta-blockers, I1-Imidazolin-receptor agonists).

Related Experiment Videos

Main Results:

  • Evidence suggests sympathetic overactivity plays a significant role in hypertension in CRF.
  • Sympathetic overactivity contributes to the progression of renal failure.
  • Sympatholytic agents are being investigated for their potential to mitigate these effects.

Conclusions:

  • Sympathetic overactivity is an important factor in hypertension and progression of chronic renal failure.
  • Targeting sympathetic overactivity presents a promising therapeutic avenue for CRF patients.
  • Further research into sympatholytic drugs is crucial for improving outcomes in renal patients.